Total Synthesis of 9,10-Dideoxy-${\beta}$-rhodomycinone

9,10-Dideoxy-${\beta}$-rhodomycinone의 합성

  • In Ho Cho (Department of Chemistry, Chonbuk National University) ;
  • Young Soy Rho (Department of Chemistry, Chonbuk National University) ;
  • Sang Moon Sho (Department of Chemistry, Chonbuk National University) ;
  • Dong Jin Yoo (Department of Chemistry, Chonbuk National University) ;
  • Jun Yong Lee (Department of Chemistry, Chonbuk National University) ;
  • Byoung Ku Han (Department of Chemistry, Chonbuk National University)
  • 조인호 (전북대학교 자연과학대학 화학과) ;
  • 노영쇠 (전북대학교 자연과학대학 화학과) ;
  • 소상문 (전북대학교 자연과학대학 화학과) ;
  • 유동진 (전북대학교 자연과학대학 화학과) ;
  • 이준용 (전북대학교 자연과학대학 화학과) ;
  • 한병구 (전북대학교 자연과학대학 화학과)
  • Published : 1992.12.20

Abstract

Total synthesis of 9,10-dideoxyrhodomycinone(30) which is the late-stage precursor of naturally occuring ${\beta}$-rhodomycinone(1) is described. After phthalide sulfone 4 was converted to naphthalide sulfone 12 by the several step. Michale addition of naphthalide sulfone 12 which was converted to an anion with 5-ethyl-1,3-cyclohexenone(21) gave a good yield of linearly condensed tetracyclic ketone compound 26. The keto group of 26 was reduced with sodium borohydride and protected by methyl group to afford compound 28. 9,10-Dideoxy-${\beta}$-rhodomycinone(30) was synthesized from pentamethoxy tetracyclic compound 28 by oxidative demethylation and demethylation of 29.

${\beta}$-rhodomycinone(1)의 전 단계물질인 9,10-dideoxyrhodomycinone(30)의 전 합성이 이루어졌다. Phthalide sulfone 4를 몇 단계의 반응을 진행시켜서 naphthalide sulfone 12로 변형시킨 뒤, 음이온으로 변형된 naphthalide sulfone 12를 5-ethyl-1,3-cyclohexenone(21)과 Michael 부가반응시켜서 선형으로 결합된 tetracyclic 케톤 화합물 26을 좋은 수율로 얻었다. 화합물 26의 케톤기는 sodium borohydride로 환원시키고 메틸기로 보호하여 화합물 28을 얻었다. 9,10-Dideoxy-${\beta}$-rhodomycinone(30)은 pentamethoxy tetracyclic 화합물 28을 oxidative demethylation시키고 메틸기를 제거시켜서 합성하였다.

Keywords

References

  1. Chem. Ber. v.88 H. Brockmann;B. Frank
  2. The Chemistry of Antitumor Antibiotics W. R. Remers
  3. Current Status and Development S. T. Crooke;S. D. Reich;Anthracyclines(Ed.)
  4. Doxorubicin, Anticancer Antibiotucs J. Arcamone
  5. Angew. Chem. Int. Ed. Engl. v.25 K. Krohn
  6. Fortsch. Chem. Org. Naturst. v.55 K. Krohn
  7. Angew. Chem. Int. Ed. Engl. v.25 K. Krohn
  8. J. Chem. Ind. (London) M. Broadhurst;C. H. Hassall;G. Thomas
  9. J. Chem. Soc., Chem. Commun. H. Fujioka;H. Yamamoto;H. Kondo;H. Annoura;Y. Kita
  10. Chem. Pharm. Bull. v.37 H. Fujioka;H. Kondo;H. Annoura;H. Yamamoto;T. Ko;Y. Kita;Y. Tamura;K. Aoe
  11. Tetrahedron Lett. v.30 A. Genot;J.-C. Florent;C. Monneret
  12. Tetrahedron v.42 K. Krohn;U. Muller
  13. J. Org. Chem. v.54 F. M. Hauser;P. Hewawasam;Young, S. Rho
  14. J. Org. Chem. v.45 F. M. Hauser;R. P. Rhee
  15. J. Kor. Chem. Soc. v.32 Inho Cho;Jinsoon Chung;Young S. Rho;R. P. Rhee
  16. J. Kor. Chem. Soc. v.30 Inho Cho;R. P. Rhee;Young, S. Rho
  17. J. Am. Chem. Soc. v.83 W. S. Wadworth, Jr.;W. D. Emmons
  18. J. Org. Chem. v.50 W. R. Michael;N. Michael
  19. J. Am. Chem. Soc. v.90 E. J. Corey;N. W. Gilman;B. E. Ganem
  20. J. Am. Chem. Soc. v.73 J. P. Blanchard;H. L. Goering
  21. J. Org. Chem. v.47 F. M. Hauser;S. Prassanna
  22. J. Am. Chem. Soc. v.72 R. L. Frank;H. K. Hall
  23. Modern Synthetic Reactions H. O. Hause
  24. J. Am. Chem. Soc. v.104 R. K. Boeckman, Jr.;F.-W. Sum
  25. J. Am. Chem. Soc. v.101 F. M. Hauser;R. P. Rhee
  26. J. Am. Chem. Soc. v.103 F. M. Hauser;S. Prassanna
  27. Synthesis L. Syper;K. Kloc;J. Milochowski;Z. Szulc
  28. Tetradedron Lett. v.22 A. S. Kende;J. P. Gesson;T. P. Demuth
  29. Tetrahedron v.40 B. A. Keay;R. Rodrigo
  30. Chem. Ber. v.96 H. Brockmann;P. Boldt;J. Niemeyer
  31. Chem. Ber. v.98 H. Brockmann;J. Niemeyer;H. Brockmann, Jr.;H. Budzikiewicz
  32. Tetrahedron Lett. v.45 H. Brockmann;H. Brockmann, Jr.;J. Niemeyer
  33. Tetrahedron Lett. H. Brockmann;T. Waechneldt;J. Niemeyer